Forum for Science, Industry and Business

Sponsored by:     3M 
Search our Site:

 

New test detects cirrhosis of the liver in an early stage

08.03.2004


Ghent researchers have developed a new and easy method of detecting cirrhosis of the liver. This major finding helps predict the evolution of chronic liver disease, allowing physicians to start proper treatment early on. Patients suffering from this serious, progressive disease in its cirrhosis stage have a high chance of developing liver cancer. The test developed in Ghent permits frequent, non-invasive analyses to be carried out, through which the critical stages of the disease can be closely monitored.



Chronic liver disease: life-threatening and progressive

Millions of people worldwide suffer from chronic liver disease. The major causes are infection by one of the hepatitis viruses and excessive use of alcohol. The liver is a very complex organ, where more than 500 metabolic functions take place, including clearing toxic substances from our body and producing proteins that coagulate the blood following wounds. Liver problems have a high rate of incidence and - after cancer and cardiovascular disorders - they are the third cause of death among people between 40 and 65.


The most problematic aspect of chronic liver disease is liver fibrosis, in which connective tissue grows throughout the liver, disrupting the composition of this complex organ and, in time, its functioning as well. Depending on its cause and on the patient, liver fibrosis can evolve rapidly or slowly. There are several distinct stages. One of the final stages is cirrhosis of the liver. When a patient develops cirrhosis, the chance of liver cancer rises sharply (25 to 40 times higher than normal) and in a very advanced stage the liver is no longer able to function. The only possibility at that point is a liver transplant - an extremely complicated intervention.

Current treatment is problematic

In order to decide which treatment is appropriate for a particular patient with liver fibrosis, doctors need to know which stage the liver disease is in. As soon as cirrhosis has set in, they will want to start tracking the possible development of liver cancer, which can occur at any moment. Of course, early detection and appropriate treatment is vital. But this is precisely the problem. Today, the only way to detect cirrhosis is through a biopsy - where a tissue sample is taken by injecting a needle through the skin into the liver. Biopsy is not entirely risk-free and is very expensive (about 1500 euro per patient).

Ghent discovery enables quick, inexpensive test

VIB researcher Nico Callewaert and his colleagues in the team of Roland Contreras (Dept. for Molecular Biomedical Research, Ghent University) have developed a new method that only requires a little blood in order to detect the cirrhosis stage reliably. In a test group of patients, the researchers succeeded in detecting 70 – 80% of the early liver cirrhoses. Not a single patient was diagnosed incorrectly. The new test detects changes in the quantities of the various sugars that are produced by the liver, which occur in the transition from fibrosis to cirrhosis. The researchers have been able to measure the sugar changes quite accurately with advanced instrumentation that is already being used in clinical laboratories, but for genetic tests.

A hopeful future

The test is now being perfected. Through future collaborations with industry, the researchers hope to arrive at a test that is easy to use and that shows 100% specificity for cirrhosis of the liver. The test could then be used to follow people with chronic hepatitis C viral infection. Often, 10 years can pass between the first diagnosis and the development of cirrhosis of the liver. An annual test could quickly detect a change and be able to predict an early stage of cirrhosis. Nico Callewaert comments: ‘We hope to be able to alert patients when the chance of liver cancer increases sharply. At that moment, the doctor can test frequently for the presence of cancer cells and detect the cancer early enough so that the patient can quite possibly be helped.’

Ann Van Gysel | alfa
Further information:
http://www.vib.be

More articles from Health and Medicine:

nachricht Organ-on-a-chip mimics heart's biomechanical properties
23.02.2017 | Vanderbilt University

nachricht Researchers identify cause of hereditary skeletal muscle disorder
22.02.2017 | Klinikum der Universität München

All articles from Health and Medicine >>>

The most recent press releases about innovation >>>

Die letzten 5 Focus-News des innovations-reports im Überblick:

Im Focus: Safe glide at total engine failure with ELA-inside

On January 15, 2009, Chesley B. Sullenberger was celebrated world-wide: after the two engines had failed due to bird strike, he and his flight crew succeeded after a glide flight with an Airbus A320 in ditching on the Hudson River. All 155 people on board were saved.

On January 15, 2009, Chesley B. Sullenberger was celebrated world-wide: after the two engines had failed due to bird strike, he and his flight crew succeeded...

Im Focus: Breakthrough with a chain of gold atoms

In the field of nanoscience, an international team of physicists with participants from Konstanz has achieved a breakthrough in understanding heat transport

In the field of nanoscience, an international team of physicists with participants from Konstanz has achieved a breakthrough in understanding heat transport

Im Focus: DNA repair: a new letter in the cell alphabet

Results reveal how discoveries may be hidden in scientific “blind spots”

Cells need to repair damaged DNA in our genes to prevent the development of cancer and other diseases. Our cells therefore activate and send “repair-proteins”...

Im Focus: Dresdner scientists print tomorrow’s world

The Fraunhofer IWS Dresden and Technische Universität Dresden inaugurated their jointly operated Center for Additive Manufacturing Dresden (AMCD) with a festive ceremony on February 7, 2017. Scientists from various disciplines perform research on materials, additive manufacturing processes and innovative technologies, which build up components in a layer by layer process. This technology opens up new horizons for component design and combinations of functions. For example during fabrication, electrical conductors and sensors are already able to be additively manufactured into components. They provide information about stress conditions of a product during operation.

The 3D-printing technology, or additive manufacturing as it is often called, has long made the step out of scientific research laboratories into industrial...

Im Focus: Mimicking nature's cellular architectures via 3-D printing

Research offers new level of control over the structure of 3-D printed materials

Nature does amazing things with limited design materials. Grass, for example, can support its own weight, resist strong wind loads, and recover after being...

All Focus news of the innovation-report >>>

Anzeige

Anzeige

Event News

Booth and panel discussion – The Lindau Nobel Laureate Meetings at the AAAS 2017 Annual Meeting

13.02.2017 | Event News

Complex Loading versus Hidden Reserves

10.02.2017 | Event News

International Conference on Crystal Growth in Freiburg

09.02.2017 | Event News

 
Latest News

Safe glide at total engine failure with ELA-inside

27.02.2017 | Information Technology

Fraunhofer IFAM expands its R&D work on Coatings for protection against corrosion and marine growth

27.02.2017 | Materials Sciences

Stingless bees have their nests protected by soldiers

24.02.2017 | Life Sciences

VideoLinks
B2B-VideoLinks
More VideoLinks >>>